{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:34:34Z","timestamp":1774542874484,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.neuropharm.2020.108276","type":"journal-article","created":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T01:32:22Z","timestamp":1597541542000},"page":"108276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference"],"prefix":"10.1016","volume":"179","author":[{"given":"Mark E.","family":"Bardgett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Downnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Baltes Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Muncie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin R.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108276_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tips.2005.03.009","article-title":"Stimulants and the developing brain","volume":"26","author":"Andersen","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108276_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0006-8993(02)03616-8","article-title":"Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance","volume":"957","author":"Baptista","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108276_bib3","series-title":"Atypical Antipsychotics: from Bench to Bedside","first-page":"61","article-title":"Behavioral models of atypical antipsychotic drug action","author":"Bardgett","year":"2004"},{"key":"10.1016\/j.neuropharm.2020.108276_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbr.2018.12.044","article-title":"The effects of amphetamine on working memory and locomotor activity in adult rats administered risperidone early in life","volume":"362","author":"Bardgett","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108276_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1037\/a0031972","article-title":"Adult rats treated with risperidone during development are hyperactive","volume":"21","author":"Bardgett","year":"2013","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108276_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/schbul\/sbs077","article-title":"Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia","volume":"39","author":"B\u00e9dard","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2020.108276_bib7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/npp.2011.10","article-title":"Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues","volume":"36","author":"B\u00e9dard","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108276_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0269881116668590","article-title":"Altered reward expectancy in individuals with recent methamphetamine dependence","volume":"31","author":"Bischoff-Grethe","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF00174372","article-title":"Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study","volume":"89","author":"Carr","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108276_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.euroneuro.2008.08.010","article-title":"Effects of risperidone on glutamate receptor subtypes in developing rat brain","volume":"19","author":"Choi","year":"2009","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108276_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.euroneuro.2009.09.002","article-title":"Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats","volume":"20","author":"Choi","year":"2010","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108276_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/pds.2189","article-title":"Exposure to antipsychotic medications over a 4-year period among children who initiated antipsychotic treatment before their sixth birthday","volume":"21","author":"Constantine","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.neuropharm.2020.108276_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/0269881115616383","article-title":"Early antipsychotic treatment in childhood\/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats","volume":"30","author":"De Santis","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2017.04.001","article-title":"Sex differences in aripiprazole sensitization from adolescence to adulthood","volume":"156","author":"Freeman","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108276_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pbb.2015.01.007","article-title":"Early-life risperidone administration alters maternal-offspring interactions and juvenile play fighting","volume":"130","author":"Gannon","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108276_bib16","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1542\/peds.2014-0992","article-title":"Committee on Substance Abuse. Attention-deficit\/hyperactivity disorder and substance abuse","volume":"134","author":"Harstad","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2020.108276_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present \u2013 a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13034-017-0192-1","article-title":"A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012","volume":"11","author":"Kalverdijk","year":"2017","journal-title":"Child Adolesc. Psychiatr. Ment. Health"},{"key":"10.1016\/j.neuropharm.2020.108276_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ps.2008.59.5.554","article-title":"Use of antipsychotic drugs among Dutch youths between 1997 and 2005","volume":"59","author":"Kalverdijk","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.neuropharm.2020.108276_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pbb.2015.02.019","article-title":"Sex differences in conditioned nicotine reward are age-specific","volume":"132","author":"Lenoir","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108276_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105640","article-title":"Childhood ADHD and risk for substance dependence in adulthood: a longitudinal, population-based study","volume":"9","author":"Levy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2020.108276_bib22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.pharep.2016.06.003","article-title":"Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats","volume":"68","author":"Lian","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2020.108276_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ejn.12401","article-title":"Estrogen potentiates the behavioral and nucleus accumbens dopamine response to continuous haloperidol treatment in female rats","volume":"39","author":"Madularu","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108276_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(01)00164-4","article-title":"Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice","volume":"121","author":"Manzanedo","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108276_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pbb.2009.12.007","article-title":"Individual differences in activity predict locomotor activity and conditioned place preference to amphetamine in both adolescent and adult rats","volume":"95","author":"Mathews","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108276_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.euroneuro.2006.10.004","article-title":"Effects of risperidone on dopamine receptor subtypes in developing rat brain","volume":"17","author":"Moran-Gates","year":"2007","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108276_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00429171","article-title":"Dopaminergic supersensitivity after neuroleptics: time-course and specificity","volume":"60","author":"Muller","year":"1978","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108276_bib28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108276_bib29","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2020.108276_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainresbull.2013.07.009","article-title":"Effects of risperidone on the acquisition and reinstatement of the conditioned place preference induced by MDMA","volume":"98","author":"Roger-S\u00e1nchez","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2020.108276_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2011.03.003","article-title":"Role of the dopamine transporter in mediating the neuroleptic-induced reduction of tyrosine hydroxylase-immunoreactive midbrain neurons","volume":"1394","author":"Reynolds","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108276_bib32","first-page":"245","article-title":"Prevention of substance use in children\/adolescents with mental disorders: a systematic review","volume":"21","author":"Salvo","year":"2012","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108276_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pnpbp.2013.06.008","article-title":"Can antipsychotic treatment contribute to drug addiction in schizophrenia?","volume":"52","author":"Samaha","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108276_bib34","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"Breakthrough dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108276_bib35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/jama.2015.0763","article-title":"Medicaid prior authorization policies for pediatric use of antipsychotic medications","volume":"313","author":"Schmid","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2020.108276_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2020.108276_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(82)90685-0","article-title":"Dopaminergic substrates of amphetamine-induced place preference conditioning","volume":"253","author":"Spyraki","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108276_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FBP.0000000000000230","article-title":"Delayed yet persistent effects of daily risperidone on activity in developing rats","volume":"27","author":"Stevens","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2017.07.025","article-title":"Early-life risperidone enhances locomotor responses to amphetamine during adulthood","volume":"812","author":"Stubbeman","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7850","article-title":"Antipsychotic treatment among youths with attention-deficit\/hyperactivity disorder","volume":"2","author":"Sultan","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuropharm.2020.108276_bib41","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/schbul\/sbr006","article-title":"Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis","volume":"38","author":"Tadokoro","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2020.108276_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.expneurol.2011.12.003","article-title":"Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat","volume":"234","author":"van Bregt","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib43","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1017\/S1461145712001642","article-title":"Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function","volume":"16","author":"Vinish","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drugalcdep.2013.02.024","article-title":"Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition","volume":"129","author":"Yates","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108276_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pbb.2011.07.012","article-title":"High impulsivity in rats predicts amphetamine conditioned place preference","volume":"100","author":"Yates","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108276_bib46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrn1919","article-title":"The role of the basal ganglia in habit formation","volume":"7","author":"Yin","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108276_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semcdb.2009.01.004","article-title":"Trafficking of dopamine transporters in psychostimulant actions","volume":"20","author":"Zahniser","year":"2009","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2020.108276_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbr.2008.10.019","article-title":"Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats","volume":"198","author":"Zakharova","year":"2009","journal-title":"Behav. Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820303440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:05:56Z","timestamp":1758438356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820303440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":48,"alternative-id":["S0028390820303440"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108276","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108276"}}